Literature DB >> 19057526

Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).

Jeannette M Beasley1, Brett A Ange, Cheryl A M Anderson, Edgar R Miller Iii, Janet T Holbrook, Lawrence J Appel.   

Abstract

Obestatin, derived from the same gene as the hunger hormone ghrelin, may reduce food intake in animals. The role of obestatin in human physiology is unclear. We evaluated cross-sectional associations between participant characteristics and fasting levels of obestatin as well two other hormones associated with energy balance, ghrelin and leptin. Data are from the baseline visit of the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OMNI-Heart) Trial that enrolled adults with elevated blood pressure (systolic 120-159 mm Hg or a diastolic of 80-99 mm Hg) but who were otherwise healthy. Partial Spearman's correlations and linear regression models estimated the association between age, gender, BMI, physical activity, and smoking with fasting hormones. Obestatin was directly associated with ghrelin (r = 0.45, P < 0.05). On average, overweight (BMI 25-30) and obese (BMI > 30) individuals had obestatin concentrations that were 12.6 (s.d. 8.8) and 25.4 (s.d. 8.4) pg/ml lower compared to normal weight (BMI < 25) individuals, respectively (P for trend = 0.002). Overweight (BMI 25-30) and obese (BMI > 30) individuals had ghrelin concentrations that were 161.7 (s.d. 69.6) and 284.7 (s.d. 66.5) pg/ml lower compared to normal weight (BMI < 25) individuals, respectively (P for trend <0.0001). A 5 unit increase in BMI was associated with 41.3% (s.d. 4.3%) (P < 0.0001) higher leptin. Obestatin and ghrelin are directly correlated and share the same patterns of association with participant characteristics. Modifiable risk factors for chronic diseases, such as BMI, are associated with fasting levels of leptin, obestatin, and ghrelin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057526      PMCID: PMC2855218          DOI: 10.1038/oby.2008.551

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  19 in total

1.  Sleep, ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention.

Authors:  A J Littman; M V Vitiello; K Foster-Schubert; C M Ulrich; S S Tworoger; J D Potter; D S Weigle; A McTiernan
Journal:  Int J Obes (Lond)       Date:  2006-08-15       Impact factor: 5.095

2.  Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents.

Authors:  Philippe Zizzari; Romaine Longchamps; Jacques Epelbaum; Marie Thérèse Bluet-Pajot
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

3.  Relationship of ghrelin and leptin hormones with body mass index and waist circumference in a random sample of adults.

Authors:  Veronica Monti; Joseph J Carlson; Steven C Hunt; Ted D Adams
Journal:  J Am Diet Assoc       Date:  2006-06

Review 4.  Obestatin: its physicochemical characteristics and physiological functions.

Authors:  Sheng-Qiu Tang; Qing-Yan Jiang; Yong-Liang Zhang; Xiao-Tong Zhu; Gang Shu; Ping Gao; Ding-Yuan Feng; Xiu-Qi Wang; Xiao-Ying Dong
Journal:  Peptides       Date:  2008-01-31       Impact factor: 3.750

5.  Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men.

Authors:  N F Chu; M J Stampfer; D Spiegelman; N Rifai; G S Hotamisligil; E B Rimm
Journal:  Int J Obes Relat Metab Disord       Date:  2001-01

6.  Rationale and design of the Optimal Macro-Nutrient Intake Heart Trial to Prevent Heart Disease (OMNI-Heart).

Authors:  Vincent J Carey; Louise Bishop; Jeanne Charleston; Paul Conlin; Tate Erlinger; Nancy Laranjo; Phyllis McCarron; Edgar Miller; Bernard Rosner; Janis Swain; Frank M Sacks; Lawrence J Appel
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

7.  Circulating preprandial ghrelin to obestatin ratio is increased in human obesity.

Authors:  Zhi-Fu Guo; Xing Zheng; Yong-Wen Qin; Jian-Qiang Hu; Shao-Ping Chen; Zheng Zhang
Journal:  J Clin Endocrinol Metab       Date:  2007-02-13       Impact factor: 5.958

8.  Circulating obestatin levels and the ghrelin/obestatin ratio in obese women.

Authors:  Valentina Vicennati; Silvia Genghini; Rosaria De Iasio; Francesca Pasqui; Uberto Pagotto; Renato Pasquali
Journal:  Eur J Endocrinol       Date:  2007-09       Impact factor: 6.664

9.  Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa.

Authors:  Toshihiro Nakahara; Toshiro Harada; Daisuke Yasuhara; Nobuhiro Shimada; Haruka Amitani; Takeo Sakoguchi; Mayra Mayumi Kamiji; Akihiro Asakawa; Akio Inui
Journal:  Biol Psychiatry       Date:  2007-10-24       Impact factor: 13.382

10.  Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal.

Authors:  M S B Huda; B H Durham; S P Wong; D Deepak; D Kerrigan; P McCulloch; L Ranganath; J Pinkney; J P H Wilding
Journal:  Int J Obes (Lond)       Date:  2007-07-31       Impact factor: 5.095

View more
  20 in total

1.  Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones.

Authors:  Anja K Büscher; Metin Cetiner; Rainer Büscher; Anne-Margret Wingen; Berthold P Hauffa; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

2.  Circulating obestatin levels in normal and Type 2 diabetic subjects.

Authors:  D H St-Pierre; F Settanni; I Olivetti; E Gramaglia; M Tomelini; R Granata; F Prodam; A Benso; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

3.  Short-,moderate-, and long-term treadmill training protocols reduce plasma, fundus, but not small intestine ghrelin concentrations in male rats.

Authors:  A Ghanbari-Niaki; A Jafari; M Moradi; R R Kraemer
Journal:  J Endocrinol Invest       Date:  2010-12-23       Impact factor: 4.256

4.  Aging effects on exercise-induced alternations in plasma acylated ghrelin and leptin in male rats.

Authors:  Ya-Wen Hsu; Yi-Ju Pan; Yu-Min Cho; Tsan-Hon Liou; Pesus Chou; Paulus S Wang
Journal:  Eur J Appl Physiol       Date:  2010-11-03       Impact factor: 3.078

Review 5.  Satiety Associated with Calorie Restriction and Time-Restricted Feeding: Peripheral Hormones.

Authors:  Debra K M Tacad; Ashley P Tovar; Christine E Richardson; William F Horn; Giri P Krishnan; Nancy L Keim; Sridevi Krishnan
Journal:  Adv Nutr       Date:  2022-06-01       Impact factor: 11.567

6.  Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels.

Authors:  Angela Kong; Marian L Neuhouser; Liren Xiao; Cornelia M Ulrich; Anne McTiernan; Karen E Foster-Schubert
Journal:  Nutr Res       Date:  2009-11       Impact factor: 3.315

7.  Sex-based differences in the behavioral and neuronal responses to food.

Authors:  Marc-Andre Cornier; Andrea K Salzberg; Dawnielle C Endly; Daniel H Bessesen; Jason R Tregellas
Journal:  Physiol Behav       Date:  2010-01-22

8.  Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior.

Authors:  Annette Horstmann; Franziska P Busse; David Mathar; Karsten Müller; Jöran Lepsien; Haiko Schlögl; Stefan Kabisch; Jürgen Kratzsch; Jane Neumann; Michael Stumvoll; Arno Villringer; Burkhard Pleger
Journal:  Front Hum Neurosci       Date:  2011-06-10       Impact factor: 3.169

Review 9.  The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines.

Authors:  John Palios; Nikolaos P E Kadoglou; Stylianos Lampropoulos
Journal:  Exp Diabetes Res       Date:  2011-12-08

Review 10.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.